Search

everythinglearnresearchcommunity

for

Search:↓

Keloid skin disorder involves abnormal fibroblast activation and immune response, linked to a group of genes including FGF11.

ULBP3 levels are higher in Tinea capitis patients and may help predict the disease's severity.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

A man lost all his hair as a rare side effect after hepatitis C treatment.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

PPAR-γ may be a key target for treating alopecia areata and other skin conditions.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

Dengue virus can infect human hair follicle cells and may cause hair loss.

Finasteride can cause a unique skin reaction on the penile shaft.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

Recognizing and treating skin symptoms in essential thrombocythemia is crucial for patient quality of life.

Early treatment with immunoglobulin and aspirin reduces heart complications in children with Kawasaki disease.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

Early diagnosis and aggressive treatment are crucial for Cicatricial Alopecia, and treatment effectiveness varies among patients.

Lichen Planopilaris is a hair loss condition best treated early with various medications, including hydroxychloroquine, to prevent permanent baldness.

Using radiation to make mice's hair turn gray helps study and find ways to prevent or reverse hair graying.

A woman's eyelashes grew thicker and longer after taking topiramate, but returned to normal when she stopped the medication.

Specific immune cells cause alopecia areata and blocking certain proteins can prevent it.

N-acetyl-GED may help prevent and partially reverse a process that leads to scarring hair loss.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

PPAR-γ is important for healthy hair and its problems, and more research on PPAR-γ treatments is needed.

The document suggests a rare skin condition might be caused by a genetic phenomenon.

Oral valganciclovir improved a patient's skin condition caused by immunosuppression.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Finasteride helps female-pattern hair loss.

Warfarin can rarely cause hair loss, which is usually reversible.

Pioglitazone usually doesn't effectively treat or cure lichen planopilaris.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

N-acetylcysteine and ImuVert can prevent hair loss in rats caused by chemotherapy.